Navigation Links
Sunrise Reports Preliminary Selected Financial and Operating Data for Fourth-Quarter 2007
Date:3/3/2008

and

revenue recognition related to the Company's Greystone subsidiary, as

described below. This represents an increase of $10 million from the

previously disclosed $130 million cumulative net income adjustments and

is due to a number of miscellaneous adjustments.

-- The Company also expects to record non-cash compensation expense

totaling approximately $44 million pre-tax ($27 million after tax)

related to the impact of the stock option adjustments described in the

Company's release dated November 9, 2007.

-- The Company has now determined that it will be required to adjust its

revenue recognition policies related to its Greystone subsidiary, a

developer and manager of continuing care retirement communities. From

the acquisition date of May 10, 2005 through December 31, 2005,

revenues were recognized based on cash received under the contract.

The cash payments corresponded to project completion milestones as set

forth in the agreements. During the course of the accounting

restatement Sunrise determined that revenue earned under these

contracts should be recognized upon completion of the contract. There

is no change in the amount or timing of the cash flow earned from the

contracts. The total impact of the adjustment is expected to reduce

pretax income by approximately $14 million.

-- More than 40 percent of the $140 million estimated cumulative net

income impact of the restatement adjustments (excluding stock option

expense and Greystone adjustments) relates to periods prior to

2003 and, therefore, will be reflected as a reduction in the opening

balance of retained earnings as of January 1, 2003 in the Company's

restated financial statements when filed. The Company continues to

expect that due to expiration of guarantees, refinanci
'/>"/>

SOURCE Sunrise Senior Living, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Sunrise Announces Release Date for Fourth-Quarter Preliminary Selected Financial and Operating Data
2. Sunrise to Unveil New Residence for Seniors at Clayton on the Park
3. Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
4. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
5. Sunrise Senior Living Opens First Custom-Built Community for Early, Mid and Late Stage Alzheimers Care Programs
6. Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007
7. Eclipsys Sunrise Acute Care Receives CCHIT Certification
8. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
9. SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America
10. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
11. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...YORK, Nov. 21 Milvia Lopez, by her...y, recently filed suit, in Supreme Court, New York...t alleges that while Ms. Lopez underwent a routine...NCENT,S HOSPITAL , doctors used an HIV infected sc...eges that several hours after being discharged fro...
(Date:11/21/2009)... Innovative medical apparel company launc... San Clemente, Calif. (PRWEB...akthrough medical apparel, today announced the lau...t Medica 2009, a leading international trade fair ...ny. Medelita inaugurates its men,s collection with...
(Date:11/20/2009)...ering Neurologist Closer to Understanding Brain Wi...swire-USNewswire/ -- Dr. Jeremy Schmahmann, Profes...rologist at the Massachusetts General Hospital in ...boratory,s research on the new field of study call...undation. ,, Dr. Schmahmann is an award-winning...
(Date:11/20/2009)... Senators and Congressmen in Competitive ... Health Care Vote , Washi...d congressmen running for re-election next year in...Charlie Cook, may come to regret voting for House ...ording to a breaking Zogby International/ O’...
(Date:11/20/2009)...ON-SALEM, N.C., Nov. 20 ...sion to redefine what it means to be "happy" durin...or with a specialty in family counseling and chair...iversity, Gladding says research shows that it is ...ss and even depression during the holidays. ,, ...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2
...,s first phase one FDA-approved clinical trial usi... will be conducted by a team of University of Lou...first time, patients with advanced heart disease w...,s own cardiac tissue. During surgery, a small pie...
...armatel Fresenius Kabi Pty Ltd, one of Australia,s...l companies, has chosen the RIVA System (Robotic I...IV syringes and bags - from Intelligent Hospital S...tem and Pharmatel Fresenius Kabi,s continued inves...
...eon Inc. (Nasdaq:, EMAG ), a leader in enterprise...als and health care networks, announced today that... Inc. (OTC Bulletin Board: HSSO) that it does not,...r was,scheduled to close today, February 11, 2009,...
... Prevention Through Screenings , ...What better time than February, National Cancer Pr...ealth is in their own hands? ZocDoc, the service t...nth. Now more than ever, New Yorkers are able to m...
...able someone is to have compassion for others , ...es may play a role in a person,s ability to empath...ice. , Researchers trained highly social mice to i...train of mice that were less social didn,t make th...
...s as Medicare-negotiated drug pricing or a ,nation...Y, Feb. 11 (HealthDay News) -- A broad swath of Am...ed overhaul of the U.S. health care system, especi...nge, a new Harris Interactive/HealthDay poll fin...
Other Medicine News:Health News:World's First Cardiac Adult Stem Cell Trial to Take Place in Louisville 2Health News:Australia's Leading Oncology Drug Compounder Chooses RIVA System 2Health News:Emageon Provides Update Regarding Merger Transaction 2Health News:Emageon Provides Update Regarding Merger Transaction 3Health News:ZocDoc Joins the Fight Against Cancer 2Health News:Empathy Might Be in the Genes 2Health News:Poll Shows Strong Support for Obama Health Care Reforms 2Health News:Poll Shows Strong Support for Obama Health Care Reforms 3Health News:Poll Shows Strong Support for Obama Health Care Reforms 4Health News:Poll Shows Strong Support for Obama Health Care Reforms 5
(Date:11/19/2009)..., , LOVELAND, Colo., Nov. 19 /PRNewswire-F...ance its customers, experience, Heska Corporation ...ced today the launch of its new and improved websi...nths of analysis, design and programming to align ...rategic objectives. ,, (Logo: http://www.new...
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswi...daq: ALXA ) announced today that its corporate pr...nual Piper Jaffray Health Care Conference on Wedne... The presentation will be webcast from The New Yor...y Thomas B. King, Alexza President and CEO. ,...
(Date:11/19/2009)..., , ABBOTT PARK, Ill., Nov. 19 /PRNewswire-...bott (NYSE: ABT ) as one of its Most Admired Cor... The Deal honored Abbott as its Most Admired De...trategic use of acquisitions and divestitures sinc... has reshaped its business portfolio with a focus ...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3New Clues to Race Gap in Breast Cancer Outcomes 50984 1New Clues to Race Gap in Breast Cancer Outcomes 50984 2New Clues to Race Gap in Breast Cancer Outcomes 50984 3Video 3A Perot Systems Unveils Series of Healthcare Video Case Studies 50979 1Video 3A Perot Systems Unveils Series of Healthcare Video Case Studies 50979 2International conference on reproductive science to be held in Pittsburgh July 18 22 50975 1International conference on reproductive science to be held in Pittsburgh July 18 22 50975 2
...racts highlight VELCADE efficacy in broad range,of...GE, Mass., June 19, 2007 /PRNewswire-FirstCall/ --...that data for,VELCADE, the market leading therapy ...s with previously treated multiple myeloma,(MM), w...oma,Workshop (IMW) in Kos, Greece, June 25-30, 200...
... 2007 /PRNewswire-FirstCall/ -- Vical,Incorporated...s MG,Inc. reported positive results following int...o complete a Phase 3 trial of an,angiogenesis prod...y. Based on the findings that the primary efficacy...istical,significance and that there were no major ...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: